Finance

Lists
Why is AFT up 2,89%?
Dive Deeper
AFT:NZE
AFT Pharmaceuticals Ltd
NZ$4,63
+2,89%
(+0,13) 1D
5 Nov., 16:59:54 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
NZ$4,52
High
NZ$4,64
Low
NZ$4,52
Mkt. cap
474,56 m
Avg. vol.
21,69 k
Volume
2,36 k
Dividend
0,54%
Quarterly dividend
NZ$0,01
Ex-dividend date
18 Jun. 2026
P/E ratio
32,96
52-wk high
NZ$4,85
52-wk low
NZ$3,02
EPS
NZ$0,14
Shares outstanding
104,87 m
No. of employees
126
Open
NZ$4,52
High
NZ$4,64
Low
NZ$4,52
Mkt. cap
474,56 m
Avg. vol.
21,69 k
Volume
2,36 k
Dividend
0,54%
Quarterly dividend
NZ$0,01
Ex-dividend date
18 Jun. 2026
P/E ratio
32,96
52-wk high
NZ$4,85
52-wk low
NZ$3,02
EPS
NZ$0,14
Shares outstanding
104,87 m
No. of employees
126
News stories
From web sources and news partners
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees126
Founded1997
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteaftpharm.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
57,47 m
57,47 m
69,88 m
69,88 m
Cost of goods sold
32,63 m
32,63 m
39,45 m
39,45 m
Cost of revenue
32,63 m
32,63 m
39,45 m
39,45 m
Research and development expenses
3,06 m
3,06 m
1,86 m
1,86 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,10 m
19,10 m
18,83 m
18,83 m
Operating expense
22,48 m
22,48 m
20,58 m
20,58 m
Total operating expenses
55,10 m
55,10 m
60,03 m
60,03 m
Operating income
2,37 m
2,37 m
9,85 m
9,85 m
Other non operating income
462,50 k
462,50 k
-886,50 k
-886,50 k
EBT including unusual items
2,22 m
2,22 m
8,72 m
8,72 m
EBT excluding unusual items
2,22 m
2,22 m
8,72 m
8,72 m
Income tax expense
856,50 k
856,50 k
3,04 m
3,04 m
Effective tax rate
38,61%
38,61%
34,88%
34,88%
Other operating expenses
318,00 k
318,00 k
-113,00 k
-113,00 k
Net income
1,65 m
1,65 m
5,72 m
5,72 m
Net profit margin
2,87%
2,87%
8,18%
8,18%
Earnings per share
-
-
-
-
Interest and investment income
2,50 k
2,50 k
500,00
500,00
Interest expense
-615,00 k
-615,00 k
-628,00 k
-628,00 k
Net interest expenses
-612,50 k
-612,50 k
-627,50 k
-627,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
3,07 m
3,07 m
11,00 m
11,00 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme